These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15290920)

  • 1. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis.
    Naganuma M; Funakoshi S; Sakuraba A; Takagi H; Inoue N; Ogata H; Iwao Y; Ishi H; Hibi T
    Inflamm Bowel Dis; 2004 May; 10(3):251-7. PubMed ID: 15290920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte adsorptive apheresis for pediatric patients with ulcerative colitis.
    Tomomasa T; Kobayashi A; Kaneko H; Mika S; Maisawa S; Chino Y; Syou H; Yoden A; Fujino J; Tanikawa M; Yamashita T; Kimura S; Kanoh M; Sawada K; Morikawa A
    Dig Dis Sci; 2003 Apr; 48(4):750-4. PubMed ID: 12741466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and clinical efficacy of granulocyte and monocyte adsorptive apheresis therapy for ulcerative colitis.
    Yamamoto T; Umegae S; Matsumoto K
    World J Gastroenterol; 2006 Jan; 12(4):520-5. PubMed ID: 16489663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
    Kanke K; Nakano M; Hiraishi H; Terano A
    Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study.
    Sacco R; Romano A; Mazzoni A; Bertini M; Federici G; Metrangolo S; Parisi G; Nencini C; Giampietro C; Bertoni M; Tumino E; Scatena F; Bresci G
    J Crohns Colitis; 2013 Dec; 7(12):e692-7. PubMed ID: 23870727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study.
    Suzuki Y; Yoshimura N; Saniabadi AR; Saito Y
    Dig Dis Sci; 2004 Apr; 49(4):565-71. PubMed ID: 15185858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis.
    Dignass A; Akbar A; Baumgart DC; Bommelaer G; Bouguen G; Cadiot G; Gillessen A; Grimaud JC; Hart A; Hoque S; Makins R; Michiels C; Moreau J; Premchand P; Ramlow W; Schanz S; Subramanian S; von Tirpitz C; Bonaz B
    Scand J Gastroenterol; 2018 Apr; 53(4):442-448. PubMed ID: 29513111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study.
    Shimoyama T; Sawada K; Hiwatashi N; Sawada T; Matsueda K; Munakata A; Asakura H; Tanaka T; Kasukawa R; Kimura K; Suzuki Y; Nagamachi Y; Muto T; Nagawa H; Iizuka B; Baba S; Nasu M; Kataoka T; Kashiwagi N; Saniabadi AR
    J Clin Apher; 2001; 16(1):1-9. PubMed ID: 11309823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis.
    Suzuki Y; Yoshimura N; Fukuda K; Shirai K; Saito Y; Saniabadi AR
    Dig Dis Sci; 2006 Nov; 51(11):2031-8. PubMed ID: 17004123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Granulocyte and monocyte adsorption apheresis in Korean conventional treatment-refractory patients with active ulcerative colitis: a prospective open-label multicenter study].
    Kim HJ; Kim JS; Han DS; Yang SK; Hahm KB; Lee WI; Kwon SW; Choi JH; Kim WH; Choi KY; Song IS
    Korean J Gastroenterol; 2005 Jan; 45(1):34-44. PubMed ID: 15665566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.
    Dignass A; Akbar A; Hart A; Subramanian S; Bommelaer G; Baumgart DC; Grimaud JC; Cadiot G; Makins R; Hoque S; Bouguen G; Bonaz B
    J Crohns Colitis; 2016 Jul; 10(7):812-20. PubMed ID: 26818659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
    Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
    Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.
    Sands BE; Sandborn WJ; Wolf DC; Katz S; Safdi M; Schwartz DA; Hanauer SB
    J Clin Gastroenterol; 2006 Jul; 40(6):482-9. PubMed ID: 16825929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Granulocytapheresis in inflammatory bowel disease. Efficacy of an induction plus maintenance sessions protocol at 32 weeks].
    Fernández Pérez FJ; Rodríguez F; de Sola C; Fernández Moreno N; Vera F; Rivera R; Sánchez Cantos A
    Rev Esp Enferm Dig; 2007 Nov; 99(11):628-35. PubMed ID: 18271660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan.
    Hibi T; Sameshima Y; Sekiguchi Y; Hisatome Y; Maruyama F; Moriwaki K; Shima C; Saniabadi AR; Matsumoto T
    Dig Liver Dis; 2009 Aug; 41(8):570-7. PubMed ID: 19211314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study.
    Hanai H; Watanabe F; Takeuchi K; Iida T; Yamada M; Iwaoka Y; Saniabadi A; Matsushita I; Sato Y; Tozawa K; Arai H; Furuta T; Sugimoto K; Bjarnason I
    Clin Gastroenterol Hepatol; 2003 Jan; 1(1):28-35. PubMed ID: 15017514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.
    Schultheiß C; Weischenberg R; Herrmann A; Haller B; Schmid RM; Reindl W; Huber W
    Artif Organs; 2015 Feb; 39(2):187-92. PubMed ID: 24981894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.